Screening with low-dose CT has been shown to significantly reduce lung cancer related mortality in high-risk ever-smokers. Interval cancer (IC) is a rising challenge in lung cancer screening because it usually presents in an advanced stage (stage III/IV non-small cell cancer) or is more biologically aggressive (i.e., small cell histology) and have a poorer prognosis […]
Read More